“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Genmab
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab youll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing bi...
| C-Level 12 | VP - Level75 |
| Director578 | Manager493 |
| Others1144 | |
| Structure | Email Format |
|---|---|
| <first><l>@ |
John |
| <last>@ | Smith@genmab.com |
| <first><last>@ | JohnSmith@genmab.com |
| <first>.<last>@ | John.Smith@genmab.com |
| <first>@ | John@genmab.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | Copenhagen, Capital Region of Denmark, Denmark | network connectivity, mobile, database, programming language, continuous improvement, testing, java, integrity, security, vpn, c, analytics, change management, continuous improvements, spark, presence, communication, quality assurance, cPLUSPLUS, audit, data quality, compliance, sql, cloud computing infrastructure, tcp, share, machine learning, basic, sdlc, scope, r, data science, operations, python, infrastructure, financial, gmp, rest, network concepts, sharepoint, privacy, ml, performance evaluation, cloud computing, e, dns, sas, risk, archiving, Agile, data management, collaboration, real-time |
| Application Development | New Jersey, United States | presence, privacy, database, communication, e, sas, scope, archiving, r, data quality, Agile, integrity, data management, collaboration, share |
| Application Development | Plainsboro, NJ | programming language, continuous improvement, testing, java, data security, integrity, security, analytics, disaster recovery, c, change management, sox, continuous improvements, spark, presence, communication, forecasting, cPLUSPLUS, disaster, data quality, compliance, automated testing, sql, machine learning, basic, data architecture, automation testing, scanning, data governance, scope, data science, visualization, operations, ai-driven, infrastructure, financial, python, ml, privacy, cloud computing, e, s3, Scrum, risk, Agile, data management, client service, collaboration, p2p, real-time |
| Application Development | Princeton, CA | presence, privacy, communication, e, Agile, data science, collaboration, operations |
| Application Development | Utrecht, Netherlands | presence, privacy, communication, e, sdlc, risk, Agile, compliance, security, data science, financial, collaboration, operations, infrastructure |
Genmab looking to hire in Content Writing in Copenhagen, Capital Region of Denmark, Denmark
Genmab looking to hire in Data Science in Copenhagen, Capital Region of Denmark, Denmark
Genmab looking to hire in Build & Release in Copenhagen, Capital Region of Denmark, Denmark
Aws
Amazon connect
Amazon s3
Atlassian jira
Automation anywhere
Agile
Application security
Azure devops
Ci/cd
Devops
At Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAt Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antib...
View MoreAn update from Genmab ( ($GMAB) ) is now available. On November 10, 2025, Genmab A/S announced a proposed private offering of $1.5 billion in senior secured
Read MoreGenmab won $8B bidding war for Merus, outbidding two others to acquire petosemtamab developer for $97/share after initial $81 offer.
Read MoreInvesting.com - Truist Securities raised its price target on Genmab A/S (NASDAQ:GMAB) to $49.00 from $46.00 on Monday, while maintaining a Buy rating on the
Read MoreInvesting.com - Truist Securities has raised its price target on Genmab A/S (NASDAQ:GMAB) to $49.00 from $46.00 while maintaining a Buy rating following the
Read MoreWe are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines. We are united by our core values: a passion for innovation, determination,...
Genmab operates in the Biotechnology research industry.
Genmab's revenue is $3.14b
Genmab has 1001 - 5000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.